Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |